Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.

Onglets principaux

Lê, Phu Quoc Gulbis, Béatrice Dedeken, Laurence Dupont, Sophie [UCL] Vanderfaeillie, Anna Ferster, Alina

(eng) OBJECTIVE: To evaluate the survival of patients with sickle cell disease (SCD) recorded in the Belgian SCD Registry and to assess the impact of disease-modifying treatments (DMT). METHOD: The Registry created in 2008 included patients of eight centers. All available data in 2008 were retrospectively encoded in the database. After 2008 and until 2012, all data were recorded prospectively for already registered patients as well as newly diagnosed subjects. Data were registered from neonatal screening or from diagnosis (first contact) until last follow-up or death. Data included diagnosis, demography, and outcome data. RESULTS: We collected data from 469 patients over a 5,110 patient years (PY) follow-up period. The global mortality rate was low (0.25/100 PY), although 13 patients died (2.8%) and was similar between children, adolescents (10-18 years), and young adults (P = 0.76). Out of the cohort, 185 patients received hydroxyurea at last follow-up (median duration of treatment: 10.3 years), 90 underwent hematopoietic stem cell transplantation (HSCT), 24 were chronically transfused, and 170 had never had any DMT. Hydroxyurea showed significant benefit on patients outcome as reflected by a lower mortality rate compared to transplanted individuals or people without DMT (0.14, 0.36, and 0.38 per 100 PY, respectively) and by higher Kaplan-Meier estimates of 15 year survival (99.4%) compared to HSCT (93.8%; P = 0.01) or no DMT groups (95.4%; P = 0.04). CONCLUSION: SCD mortality in Belgium is low with no increase observed in young adults. Patients treated with hydroxyurea demonstrate a significant benefit in survival when compared to those without DMT or transplanted.

Type de document Article de périodique (Journal article) – Article de recherche
Type d'accès Accès restreint
Année de publication 2015
Langue Anglais
Information sur le périodique "Pediatric Blood & Cancer" - Vol. 62, no. 11, p. 1956-1961 (2015)
Peer reviewed oui
Editeur JohnWiley & Sons, Inc. ((United States) Hoboken, NY)
issn 1545-5009
e-issn 1545-5017
Statut de la publication Publié
Affiliations UCL - SSS/IREC/PEDI - Pôle de Pédiatrie
UCL - (SLuc) Service d'hématologie et d'oncologie pédiatrique
Mots-clés Hydroxyurea ; Mortality ; Sickle cell disease ; Survival
Liens
  1. Gaston Marilyn H., Verter Joel I., Woods Gerald, Pegelow Charles, Kelleher John, Presbury Gerald, Zarkowsky Harold, Vichinsky Elliott, Iyer Rathi, Lobel Jeffrey S., Diamond Steven, Holbrook C. Tate, Gill Frances M., Ritchey Kim, Falletta John M., , Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia, 10.1056/nejm198606193142501
  2. Davies, Cochrane Database Syst Rev, 1, CD003885 (2004)
  3. Adamkiewicz T. V., Silk B. J., Howgate J., Baughman W., Strayhorn G., Sullivan K., Farley M. M., Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life, 10.1542/peds.2007-0018
  4. Yanni Emad, Grosse Scott D., Yang QuanHe, Olney Richard S., Trends in Pediatric Sickle Cell Disease-Related Mortality in the United States, 1983-2002, 10.1016/j.jpeds.2008.09.052
  5. Voskaridou E., Christoulas D., Bilalis A., Plata E., Varvagiannis K., Stamatopoulos G., Sinopoulou K., Balassopoulou A., Loukopoulos D., Terpos E., The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS), 10.1182/blood-2009-05-221333
  6. Hamideh Dima, Alvarez Ofelia, Sickle cell disease related mortality in the United States (1999-2009) : Sickle Cell Disease-Related Mortality, 10.1002/pbc.24557
  7. Lopes de Castro Lobo Clarisse, Pinto Jorge F. C., Nascimento Emilia M., Moura Patricia G., Cardoso Gilberto P., Hankins Jane S., The effect of hydroxcarbamide therapy on survival of children with sickle cell disease, 10.1111/bjh.12323
  8. Vichinsky, Pediatrics, 81, 749 (1988)
  9. Adams R. J., Nichols F. T., Figueroa R., McKie V., Lott T., Transcranial Doppler correlation with cerebral angiography in sickle cell disease, 10.1161/01.str.23.8.1073
  10. Adams Robert J., McKie Virgil C., Hsu Lewis, Files Beatrice, Vichinsky Elliott, Pegelow Charles, Abboud Miguel, Gallagher Dianne, Kutlar Abdullah, Nichols Fenwick T., Bonds Duane R., Brambilla Donald, Woods Gerald, Olivieri Nancy, Driscoll Catherine, Miller Scott, Wang Winfred, Hurlett Anne, Scher Charles, Berman Brian, Carl Elizabeth, Jones Anne M., Roach E. Steve, Wright Elizabeth, Zimmerman Robert A., Waclawiw Myron, Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography, 10.1056/nejm199807023390102
  11. Bernaudin F., Verlhac S., Arnaud C., Kamdem A., Chevret S., Hau I., Coic L., Leveille E., Lemarchand E., Lesprit E., Abadie I., Medejel N., Madhi F., Lemerle S., Biscardi S., Bardakdjian J., Galacteros F., Torres M., Kuentz M., Ferry C., Socie G., Reinert P., Delacourt C., Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort, 10.1182/blood-2010-06-293514
  12. Thomas C, , Lemerle S, Bernaudin F, Feingold J, Guillou-Bataille M, Reinert P, Drépanocytose: étude de la mortalité pédiatrique en Ile de France de 1985 à 1992, 10.1016/0929-693x(96)86402-5
  13. Neonato Maria Grazia, Guilloud‐Bataille Monique, Beauvais Pierre, Bégué Pierre, Belloy Marie, Benkerrou Malika, Ducrocq Rolande, Maier‐Redelsperger Micheline, de Montalembert Mariane, Quinet Béatrice, Elion Jacques, Feingold Josué, Girot Robert, , Acute clinical events in 299 homozygous sickle cell patients living in France, 10.1034/j.1600-0609.2000.90210.x
  14. Quinn C. T., Survival of children with sickle cell disease, 10.1182/blood-2003-11-3758
  15. Telfer P., Coen P., Chakravorty S., Wilkey O., Evans J., Newell H., Smalling B., Amos R., Stephens A., Rogers D., Kirkham F., Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London, 10.3324/haematol.10937
  16. Quinn C. T., Rogers Z. R., McCavit T. L., Buchanan G. R., Improved survival of children and adolescents with sickle cell disease, 10.1182/blood-2009-07-233700
  17. Platt Orah S., Brambilla Donald J., Rosse Wendell F., Milner Paul F., Castro Oswaldo, Steinberg Martin H., Klug Panpit P., Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death, 10.1056/nejm199406093302303
  18. Vichinsky Elliott P., Neumayr Lynne D., Earles Ann N., Williams Roger, Lennette Evelyne T., Dean Deborah, Nickerson Bruce, Orringer Eugene, McKie Virgil, Bellevue Rita, Daeschner Charles, Abboud Miguel, Moncino Mark, Ballas Samir, Ware Russell, Manci Elizabeth A., Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease, 10.1056/nejm200006223422502
  19. Powars Darleen R., Chan Linda S., Hiti Alan, Ramicone Emily, Johnson Cage, Outcome of Sickle Cell Anemia : A 4-Decade Observational Study of 1056 Patients, 10.1097/01.md.0000189089.45003.52
  20. Fitzhugh, Am J Hematol, 85, 36 (2010)
  21. Gardner Kate, Bell Cathy, Bartram Jack L., Allman Marlene, Awogbade Moji, Rees David C., Ervine Max, Thein Swee L., Outcome of adults with sickle cell disease admitted to critical care - experience of a single institution in the UK : Short Report, 10.1111/j.1365-2141.2010.08271.x
  22. Charache Samuel, Terrin Michael L., Moore Richard D., Dover George J., Barton Franca B., Eckert Susan V., McMahon Robert P., Bonds Duane R., Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia, 10.1056/nejm199505183322001
  23. Ferster, Blood, 88, 1960 (1996)
  24. Gulbis B., Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience, 10.1182/blood-2004-07-2704
  25. Ware R. E., How I use hydroxyurea to treat young patients with sickle cell anemia, 10.1182/blood-2009-04-146852
  26. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y, Dresse MF, Sariban E, Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium, 10.1038/sj.bmt.1701291
  27. Walters Mark C., Patience Melinda, Leisenring Wendy, Eckman James R., Scott J. Paul, Mentzer William C., Davies Sally C., Ohene-Frempong Kwaku, Bernaudin Françoise, Matthews Dana C., Storb Rainer, Sullivan Keith M., Bone Marrow Transplantation for Sickle Cell Disease, 10.1056/nejm199608083350601
  28. Panepinto Julie A., Walters Mark C., Carreras Jeanette, Marsh Judith, Bredeson Christopher N., Gale Robert Peter, Hale Gregory A., Horan John, Hows Jill M., Klein John P., Pasquini Ricardo, Roberts Irene, Sullivan Keith, Eapen Mary, Ferster Alina, , Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research, 10.1111/j.1365-2141.2007.06592.x
  29. Bernaudin F., Socie G., Kuentz M., Chevret S., Duval M., Bertrand Y., Vannier J.-P., Yakouben K., Thuret I., Bordigoni P., Fischer A., Lutz P., Stephan J.-L., Dhedin N., Plouvier E., Margueritte G., Bories D., Verlhac S., Esperou H., Coic L., Vernant J.-P., Gluckman E., , Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease, 10.1182/blood-2007-03-079665
  30. Dedeken Laurence, Lê Phu Q., Azzi Nadira, Brachet Cécile, Heijmans Catherine, Huybrechts Sophie, Devalck Christine, Rozen Laurence, Ngalula Malou, Ferster Alina, Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients, 10.1111/bjh.12737
  31. Rees David C, Olujohungbe Ade D., Parker Norman E., Stephens Adrian D., Telfer Paul, Wright Josh, Guidelines for the management of the acute painful crisis in sickle cell disease, 10.1046/j.1365-2141.2003.04193.x
  32. de Montalembert, Haematologica, 91, 125 (2006)
  33. de Montalembert Mariane, Ferster Alina, Colombatti Raffaella, Rees David C., Gulbis Beatrice, , ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children, 10.1002/ajh.21865
  34. Yawn Barbara P., Buchanan George R., Afenyi-Annan Araba N., Ballas Samir K., Hassell Kathryn L., James Andra H., Jordan Lanetta, Lanzkron Sophie M., Lottenberg Richard, Savage William J., Tanabe Paula J., Ware Russell E., Murad M. Hassan, Goldsmith Jonathan C., Ortiz Eduardo, Fulwood Robinson, Horton Ann, John-Sowah Joylene, Management of Sickle Cell Disease : Summary of the 2014 Evidence-Based Report by Expert Panel Members, 10.1001/jama.2014.10517
  35. Gill, Blood, 86, 776 (1995)
  36. Lanzkron, Public Health Rep, 128, 110 (2013)
  37. Strouse J. J., Lanzkron S., Beach M. C., Haywood C., Park H., Witkop C., Wilson R. F., Bass E. B., Segal J. B., Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children, 10.1542/peds.2008-0441
  38. Wang Winfred C, Ware Russell E, Miller Scott T, Iyer Rathi V, Casella James F, Minniti Caterina P, Rana Sohail, Thornburg Courtney D, Rogers Zora R, Kalpatthi Ram V, Barredo Julio C, Brown R Clark, Sarnaik Sharada A, Howard Thomas H, Wynn Lynn W, Kutlar Abdullah, Armstrong F Daniel, Files Beatrice A, Goldsmith Jonathan C, Waclawiw Myron A, Huang Xiangke, Thompson Bruce W, Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG), 10.1016/s0140-6736(11)60355-3
  39. Thornburg C. D., Files B. A., Luo Z., Miller S. T., Kalpatthi R., Iyer R., Seaman P., Lebensburger J., Alvarez O., Thompson B., Ware R. E., Wang W. C., , Impact of hydroxyurea on clinical events in the BABY HUG trial, 10.1182/blood-2012-03-419879
  40. Steinberg Martin H., Barton Franca, Castro Oswaldo, Pegelow Charles H., Ballas Samir K., Kutlar Abdullah, Orringer Eugene, Bellevue Rita, Olivieri Nancy, Eckman James, Varma Mala, Ramirez Gloria, Adler Brian, Smith Wally, Carlos Timothy, Ataga Kenneth, DeCastro Laura, Bigelow Carolyn, Saunthararajah Yogen, Telfer Margaret, Vichinsky Elliott, Claster Susan, Shurin Susan, Bridges Kenneth, Waclawiw Myron, Bonds Duane, Terrin Michael, Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia : Risks and Benefits Up to 9 Years of Treatment, 10.1001/jama.289.13.1645
  41. Steinberg, Am J Hematol, 85, 403 (2010)
  42. Gulbis Béatrice, Ferster Alice, Vermylen Christiane, Dresse Marie-Françoise, Vanderfaeillie Anna, Delannoy André, Labarque Veerle, Philippet Pierre, Kentos Alain, Sztern Bernard, Deprijck Bernard, Vertongen Françoise, An Estimation of the Incidence and Demographic Picture of the Major Hemoglobinopathies in Belgium (From a Confidential Inquiry), 10.1080/03630260802004400
  43. Miller Andrew C., Gladwin Mark T., Pulmonary Complications of Sickle Cell Disease, 10.1164/rccm.201111-2082ci
  44. Gladwin Mark T., Barst Robyn J., Gibbs J. Simon R., Hildesheim Mariana, Sachdev Vandana, Nouraie Mehdi, Hassell Kathryn L., Little Jane A., Schraufnagel Dean E., Krishnamurti Lakshmanan, Novelli Enrico, Girgis Reda E., Morris Claudia R., Berman Rosenzweig Erika, Badesch David B., Lanzkron Sophie, Castro Oswaldo L., Taylor James G., Goldsmith Jonathan C., Kato Gregory J., Gordeuk Victor R., Machado Roberto F., , Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom, 10.1371/journal.pone.0099489
Référence bibliographique Lê, Phu Quoc ; Gulbis, Béatrice ; Dedeken, Laurence ; Dupont, Sophie ; Vanderfaeillie, Anna ; et. al. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.. In: Pediatric Blood & Cancer, Vol. 62, no. 11, p. 1956-1961 (2015)
Permalien http://hdl.handle.net/2078.1/181779